Publications by authors named "Logan Wachter"

Claim this Profile
D
Disease-modifying effects of a glial-targeted inducible nitric oxide synthase inhibitor (1400W) in mixed-sex cohorts of a rat soman (GD) model of epilepsy.
Suraj S Vasanthi, Nikhil S Rao, Manikandan Samidurai, Nyzil Massey, Christina Meyer, Logan Wachter

J Neuroinflammation· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-Modifying Effects of a Glial-targeted Inducible Nitric Oxide Synthase Inhibitor (1400W) in Mixed-sex Cohorts of a Rat Soman (GD) Model of Epilepsy.
Suraj S Vasanthi, Nikhil S Rao, Manikandan Samidurai, Nyzil Massey, Christina Meyer, Logan Wachter

Res Sq· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DFP-Induced Status Epilepticus Severity in Mixed-Sex Cohorts of Adult Rats Housed in the Same Room: Behavioral and EEG Comparisons.
Nikhil S Rao, Christina Meyer, Suraj S Vasanthi, Nyzil Massey, Manikandan Samidurai, Logan Wachter

Front Cell Dev Biol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress.
Meghan Gage, Marson Putra, Logan Wachter, Kylie Dishman, Megan Gard

Antioxidants (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Impact of Severity and Duration of , Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosphate Model.
Meghan Gage, Marson Putra, Crystal Gomez-Estrada, Madison Golden, Logan Wachter

Front Cell Neurosci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis